Aberdeen Group plc Has $71.70 Million Holdings in MetLife, Inc. $MET

Key Points

• Aberdeen Group plc reduced its holdings in MetLife, Inc. by 12.8%, owning 891,562 shares worth approximately $71.7 million as of its latest SEC filing.
• MetLife reported a Q2 EPS of $2.02, missing the consensus estimate of $2.32, and had revenue of $17.34 billion, falling short of analysts' expectations.
• The company declared a quarterly dividend of $0.5675 per share, scheduled for payment on December 9, reflecting an annualized dividend yield of 2.8%.

Aberdeen Group plc trimmed its holdings in shares of MetLife, Inc. (NYSE:MET - Free Report) by 12.8% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 891,562 shares of the financial services provider's stock after selling 130,712 shares during the period. Aberdeen Group plc owned 0.13% of MetLife worth $71,699,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. North Capital Inc. acquired a new position in MetLife during the 1st quarter worth about $26,000. Motco raised its position in shares of MetLife by 105.5% during the first quarter. Motco now owns 413 shares of the financial services provider's stock worth $33,000 after acquiring an additional 212 shares during the last quarter. GFG Capital LLC acquired a new position in shares of MetLife during the second quarter valued at $38,000. Abound Wealth Management boosted its holdings in MetLife by 652.3% in the second quarter. Abound Wealth Management now owns 489 shares of the financial services provider's stock valued at $39,000 after acquiring an additional 424 shares during the last quarter. Finally, Legend Financial Advisors Inc. acquired a new stake in MetLife in the second quarter worth about $40,000. Institutional investors own 94.99% of the company's stock.

MetLife Trading Down 2.6%

Shares of NYSE MET opened at $79.88 on Friday. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.57. MetLife, Inc. has a twelve month low of $65.21 and a twelve month high of $89.05. The company's fifty day moving average is $79.68 and its 200-day moving average is $78.12. The stock has a market cap of $53.12 billion, a price-to-earnings ratio of 13.54, a P/E/G ratio of 0.72 and a beta of 0.86.

MetLife (NYSE:MET - Get Free Report) last issued its quarterly earnings data on Wednesday, August 6th. The financial services provider reported $2.02 EPS for the quarter, missing the consensus estimate of $2.32 by ($0.30). MetLife had a return on equity of 19.88% and a net margin of 5.83%.The business had revenue of $17.34 billion for the quarter, compared to analyst estimates of $18.58 billion. During the same period in the previous year, the business posted $2.28 EPS. The business's quarterly revenue was down 2.7% compared to the same quarter last year. Equities research analysts predict that MetLife, Inc. will post 9.65 EPS for the current year.

MetLife Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 9th. Investors of record on Tuesday, November 4th will be given a $0.5675 dividend. The ex-dividend date is Tuesday, November 4th. This represents a $2.27 annualized dividend and a dividend yield of 2.8%. MetLife's payout ratio is currently 38.47%.

Analyst Ratings Changes

A number of research analysts have issued reports on MET shares. Weiss Ratings restated a "buy (b)" rating on shares of MetLife in a research report on Wednesday. Morgan Stanley raised their price objective on shares of MetLife from $94.00 to $97.00 and gave the company an "overweight" rating in a research note on Tuesday, October 7th. Cowen reaffirmed a "buy" rating on shares of MetLife in a report on Friday, August 22nd. Piper Sandler downgraded MetLife from an "overweight" rating to a "neutral" rating and set a $84.00 price target on the stock. in a research note on Friday, September 19th. Finally, JPMorgan Chase & Co. lifted their price objective on MetLife from $86.00 to $95.00 and gave the stock an "overweight" rating in a research note on Tuesday, July 8th. One equities research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, MetLife has an average rating of "Moderate Buy" and an average price target of $95.18.

About MetLife

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.